Anti-coagulant [EPC]

5589 reported adverse events

Drugs of this class: ASPIRIN, CITRIC ACID, SODIUM BICARBONATE BIVALIRUDIN ARGATROBAN ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SODIUM CITRATE AND CITRIC ACID MONOHYDRATE ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE

These side effects are most commonly reported by patients taking drugs of the Anti-coagulant [EPC] class:

# Side effect Count
0 CHRONIC KIDNEY DISEASE 719
1 RENAL FAILURE 464
2 ACUTE KIDNEY INJURY 463
3 DRUG INEFFECTIVE 349
4 THROMBOSIS IN DEVICE 291
5 HAEMORRHAGE 265
6 OFF LABEL USE 263
7 END STAGE RENAL DISEASE 252
8 THROMBOSIS 225
9 HEPARIN-INDUCED THROMBOCYTOPENIA 220
See all common reactions for Anti-coagulant [EPC]

Drugs of the Anti-coagulant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION TIME ABNORMAL 128 0.5079
1 CORONARY ARTERY PERFORATION 29 0.2736
2 IMAGING PROCEDURE ARTIFACT 3 0.2500
3 THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME 3 0.2143
4 CORONARY NO-REFLOW PHENOMENON 5 0.2000
5 STENT OCCLUSION 97 0.1823
6 INTRAPERICARDIAL THROMBOSIS 4 0.1739
7 REPERFUSION INJURY 17 0.1466
8 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.1400
9 ARTERIOVENOUS FISTULA, ACQUIRED 2 0.1333
See all enriched reactions for Anti-coagulant [EPC]